FCM
MRK icon

Fourpath Capital Management’s Merck MRK Stock Holding History

Fourpath Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
18,420
+1,400
+8% +$162K 0.32% 59
2025
Q4 		$1.79M Buy
17,020
+2,399
+16% +$225K 0.25% 72
2025
Q3 		$1.23M Sell
14,621
-50
-0.3% -$4.12K 0.17% 88
2025
Q2 		$1.16M Hold
14,671
– – 0.18% 85
2025
Q1 		$1.32M Buy
14,671
+30
+0.2% +$2.8K 0.23% 80
2024
Q4 		$1.46M Sell
14,641
-101
-0.7% -$10.4K 0.27% 77
2024
Q3 		$1.67M Buy
14,742
+12,781
+652% +$1.52M 0.31% 70
2024
Q2 		$243K Sell
1,961
-46
-2% -$5.92K 0.18% 111
2024
Q1 		$265K Sell
2,007
-4
-0.2% -$493 0.18% 105
2023
Q4 		$219K Sell
2,011
-7
-0.3% -$727 0.15% 119
2023
Q3 		$208K Sell
2,018
-152
-7% -$16.4K 0.16% 110
2023
Q2 		$250K Sell
2,170
-32
-1% -$3.63K 0.3% 81
2023
Q1 		$234K Sell
2,202
-4,494
-67% -$485K 0.16% 114
2022
Q4 		$743K Sell
6,696
-3,344
-33% -$342K 0.54% 44
2022
Q3 		$865K Sell
10,040
-3,213
-24% -$287K 0.59% 42
2022
Q2 		$1.21M Sell
13,253
-1,919
-13% -$170K 0.75% 26
2022
Q1 		$1.25M Buy
15,172
+223
+1% +$17.6K 0.49% 38
2021
Q4 		$1.15M Buy
+14,949
New +$1.19M 0.44% 40

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fourpath Capital Management's MRK Position: Q1 2026 in Review

Fourpath Capital Management increased its Merck (MRK) stake by 8.2% in Q1 2026, buying an estimated $162K and bringing the position to 18,420 shares worth $2.22M. The position accounts for 0.32% of the portfolio, ranked #59.

Fourpath Capital Management first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fourpath Capital Management held 18,420 shares of Merck worth $2.22M as of Q1 2026.
  • Fourpath Capital Management bought 1,400 Merck shares in Q1 2026, an estimated $162K.
  • Merck made up 0.32% of Fourpath Capital Management's portfolio in Q1 2026, its #59 holding.
  • Fourpath Capital Management first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fourpath Capital Management's 13F filing for Q1 2026, filed 1 May 2026.